收费全文 | 40051篇 |
免费 | 16286篇 |
国内免费 | 907篇 |
2024年 | 34篇 |
2023年 | 165篇 |
2022年 | 396篇 |
2021年 | 976篇 |
2020年 | 2517篇 |
2019年 | 4121篇 |
2018年 | 4303篇 |
2017年 | 4471篇 |
2016年 | 4625篇 |
2015年 | 4846篇 |
2014年 | 4690篇 |
2013年 | 5169篇 |
2012年 | 3154篇 |
2011年 | 2704篇 |
2010年 | 3776篇 |
2009年 | 2343篇 |
2008年 | 1476篇 |
2007年 | 959篇 |
2006年 | 857篇 |
2005年 | 880篇 |
2004年 | 836篇 |
2003年 | 758篇 |
2002年 | 674篇 |
2001年 | 508篇 |
2000年 | 411篇 |
1999年 | 351篇 |
1998年 | 139篇 |
1997年 | 91篇 |
1996年 | 81篇 |
1995年 | 92篇 |
1994年 | 84篇 |
1993年 | 58篇 |
1992年 | 84篇 |
1991年 | 74篇 |
1990年 | 42篇 |
1989年 | 45篇 |
1988年 | 40篇 |
1987年 | 27篇 |
1986年 | 33篇 |
1985年 | 26篇 |
1984年 | 28篇 |
1983年 | 21篇 |
1982年 | 17篇 |
1981年 | 14篇 |
1979年 | 13篇 |
1974年 | 12篇 |
1973年 | 22篇 |
1972年 | 13篇 |
1966年 | 12篇 |
1958年 | 13篇 |
Background: Transplantation of bone marrow-derived mesenchymal stem cells (BMSCs) is a potential therapy for cerebral ischemia. However, the underlying protective mechanism remains undetermined. Here, we tested the hypothesis that transplantation of BMSCs via intravenous injection can alleviate neurological functional deficits through activating PI3K/AKT signaling pathway after cerebral ischemia in rats.
Methods: A cerebral ischemic rat model was established by the 2 h middle cerebral artery occlusion (MCAO). Twenty-four hours later, BMSCs (1?×?106 in 1 ml PBS) from SD rats were injected into the tail vein. Neurological function was evaluated by modified neurological severity score (mNSS) and modified adhesive removal test before and on d1, d3, d7, d10 and d14 after MCAO. Protein expressions of AKT, GSK-3β, CRMP-2 and GAP-43 were detected by Western-bolt. NF-200 was detected by immunofluorescence.
Results: BMSCs transplantation did not only significantly improve the mNSS score and the adhesive-removal somatosensory test after MCAO, but also increase the density of NF-200 and the expression of p-AKT, pGSK-3β and GAP-43, while decrease the expression of pCRMP-2. Meanwhile, these effects can be suppressed by LY294002, a specific inhibitor of PI3K/AKT.
Conclusion: These data suggest that transplantation of BMSCs could promote axon growth and neurological deficit recovery after MCAO, which was associated with activation of PI3K/AKT /GSK-3β/CRMP-2 signaling pathway.
相似文献Cerebral ischaemia/reperfusion (I/R) injury-induced irreversible brain injury is a major cause of mortality and functional impairment in ageing people. Gastrodin (GAS), derived from the traditional Chinese herbal medicine Tianma, has been reported to inhibit the progression of stroke, but the mechanism whereby GAS modulates the progression of cerebral I/R remains unclear. The middle cerebral artery occlusion method was used as a model of I/R in vivo. Rats were pretreated with GAS by intraperitoneal injection 7 days before I/R surgery and were then treated with GAS for 7 days after I/R surgery. Additionally, an oxygen–glucose deprivation/reoxygenation model using neuronal cells was established in vitro to simulate I/R injury. 2,3,5-Triphenyltetrazolium chloride and Nissl staining were used to evaluate infarct size and neuronal damage, respectively. Lactate dehydrogenase release and cell counting kit-8 assays were used to assess neuronal cell viability. Enzyme-linked immunosorbent assay, qPCR, flow cytometry and western blotting were performed to analyse the expression levels of inflammatory factors (IL-1β, IL-18), lncRNA NEAT1, miR-22-3p, NLRP3 and cleaved caspase-1. Luciferase reporter experiments were performed to verify the association between lncRNA NEAT1 and miR-22-3p. The results indicated that GAS could significantly improve the neurological scores of rats and reduce the area of cerebral infarction. Meanwhile, GAS inhibited pyroptosis by downregulating NLRP3, inflammatory factors (IL-1β, IL-18) and cleaved caspase-1. In addition, GAS attenuated I/R-induced inflammation in neuronal cells through the modulation of the lncRNA NEAT1/miR-22-3p axis. GAS significantly attenuated cerebral I/R injury via modulation of the lncRNA NEAT1/miR-22-3p axis. Thus, GAS might serve as a new agent for the treatment of cerebral I/R injury.
相似文献